Login / Signup

Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma.

Yavuz ArasDuygu DölenAyca IribasGözde Kılıç KayhanRejin KebudiGökçen ÜnverengilPulat Akın SabancıAli Nail İzgi
Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2021)
In corporation of molecular features to the clinicopathologic classification leads to risk-adapted treatment. Although the molecular subgroups did not affect outcome significantly in this study, more studies with larger numbers of patients are needed to understand the tumor pathophysiology of medulloblastoma and design the future medical practice.
Keyphrases
  • end stage renal disease
  • healthcare
  • ejection fraction
  • chronic kidney disease
  • machine learning
  • peritoneal dialysis
  • deep learning
  • prognostic factors
  • quality improvement
  • replacement therapy